Crescent Biopharma (CBIO) Other Gross PP&E Adjustments (2016 - 2025)
Crescent Biopharma (CBIO) has disclosed Other Gross PP&E Adjustments for 11 consecutive years, with -$1.5 million as the latest value for Q4 2025.
- Quarterly Other Gross PP&E Adjustments changed N/A to -$1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.5 million through Dec 2025, changed N/A year-over-year, with the annual reading at -$1.5 million for FY2025, N/A changed from the prior year.
- Other Gross PP&E Adjustments for Q4 2025 was -$1.5 million at Crescent Biopharma, up from -$1.6 million in the prior quarter.
- The five-year high for Other Gross PP&E Adjustments was $1.4 million in Q1 2023, with the low at -$1.6 million in Q2 2025.
- Average Other Gross PP&E Adjustments over 5 years is $32940.4, with a median of $345072.0 recorded in 2021.
- The sharpest move saw Other Gross PP&E Adjustments soared 647.49% in 2021, then tumbled 246.39% in 2024.
- Over 5 years, Other Gross PP&E Adjustments stood at $815945.0 in 2021, then surged by 68.91% to $1.4 million in 2022, then crashed by 187.58% to -$1.2 million in 2023, then soared by 60.75% to -$473770.0 in 2024, then plummeted by 210.07% to -$1.5 million in 2025.
- According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at -$1.5 million, -$1.6 million, and -$1.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.